Dual And Multi Energy Computed Tomography Market Size, Share | Report 2022-2030
The global dual and multi energy computed tomography market size was estimated at around USD 1.41 billion in 2021 and it is projected to hit around USD 2.89 billion by 2030, growing at a CAGR of 8.32% from 2022 to 2030.
Dual Source Computed Tomography is gaining large scope in recent times due to improved temporal resolution for ECG-synchronized cardiac scanning, improved spectral separation by additional pre-filtration of the high-kV beam, reduced cross-scattering, and improved dual-energy contrast. The system uses two X-ray tubes and two detectors at 90°. DSCT can be operated at twice the spiral pitch of single-source CT. The dual-source CT allows the interrogation of materials that have different attenuation properties at different energies. Whereas conventional single-energy CT produces a single image set, dual-energy data (attenuation values at two energy spectra) can be used to reconstruct numerous image types:
Scope of The Report
| Report Coverage | Details |
| Market Size in 2021 | USD 1.41 billion |
| Revenue Forecast by 2030 | USD 2.89 billion |
| Growth rate from 2022 to 2030 | CAGR of 8.32% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segmentation | Type, Application, End-Use, Region |
| Companies Covered |
GE Healthcare, Koninklijke Philips N.V., Siemens Healthineers, Canon Medical Systems Corporation, and others |
DSCT is broadly classified into two types, prospective techniques, and retrospective techniques. A technique that occurs before the patient needs to be scanned (prospective). Prospective technique is further classified into dual source, single source consecutive, single source twin-beam, single source sequential, and rapid kVPswitch. On the other hand, the retrospective technique is conducted after the patient scan and does not need prior selection. It provides a complete field view, and excellent temporal resolution, and is reconstructed in projection space. Thus, it is gaining increased momentum in the market and will continue to do so in the forecast period.
These techniques have shown promising results in clinical applications. It is adopted for the diagnosis and screening of vascular disorders (detection of endoleaks, pulmonary embolism, myocardial ischemia, decreased metal artifacts, removal of CT angiography), urinary tract infections (to the characterization of renal stones, renal cysts, and masses), neurological imaging (differentiation of hemorrhages from iodinated contrast, quantification of iodine leaks in traumatic hemorrhagic contusions), breast imaging, musculoskeletal imaging (reduction of metal artifacts, detection of bone marrow oedema), abdominal imaging and thoracic imaging. It holds numerous application areas and thus is mainly used by hospitals due to the presence of skilled staff to operate such advanced techniques. The rise in caseload and diseases that require effective diagnostic imaging services and economic stability are factors responsible for the increased adoption rate among hospitals. Other end-uses include diagnostic and ambulatory surgical centers.
Key Players
Market Segmentation
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Dual And Multi Energy Computed Tomography Market
5.1. COVID-19 Landscape: Dual And Multi Energy Computed Tomography Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Dual And Multi Energy Computed Tomography Market, By Type
8.1. Dual And Multi Energy Computed Tomography Market, by Type, 2022-2030
8.1.1 Prospective
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Retrospective
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Dual And Multi Energy Computed Tomography Market, By Application
9.1. Dual And Multi Energy Computed Tomography Market, by Application, 2022-2030
9.1.1. Vascular Neurological
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Abdominal
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Thoracic
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Urinary Tract Infections
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Musculoskeletal
9.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Dual And Multi Energy Computed Tomography Market, By End-Use
10.1. Dual And Multi Energy Computed Tomography Market, by End-Use, 2022-2030
10.1.1. Hospitals
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Diagnostic Centers
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Ambulatory Surgery Centers
10.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Dual And Multi Energy Computed Tomography Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Type (2017-2030)
11.1.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Type (2017-2030)
11.1.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.4.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Type (2017-2030)
11.1.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.5.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Type (2017-2030)
11.2.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Type (2017-2030)
11.2.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.4.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Type (2017-2030)
11.2.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.5.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Type (2017-2030)
11.2.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.6.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Type (2017-2030)
11.2.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.7.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Type (2017-2030)
11.3.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Type (2017-2030)
11.3.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.4.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Type (2017-2030)
11.3.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.5.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Type (2017-2030)
11.3.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.6.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Type (2017-2030)
11.3.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.7.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Type (2017-2030)
11.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Type (2017-2030)
11.4.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.4.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Type (2017-2030)
11.4.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.5.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Type (2017-2030)
11.4.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.6.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Type (2017-2030)
11.4.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.7.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Type (2017-2030)
11.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Type (2017-2030)
11.5.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.4.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Type (2017-2030)
11.5.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.5.3. Market Revenue and Forecast, by End-Use (2017-2030)
Chapter 12. Company Profiles
12.1. GE Healthcare
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Koninklijke Philips N.V.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Siemens Healthineers
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Canon Medical Systems Corporation
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. others
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers